Wei Chen - EUDA Health CEO Director
| EUDA Stock | 4.53 0.14 3.00% |
Insider
Wei Chen is CEO Director of EUDA Health Holdings
| Age | 39 |
| Address | 1 Pemimpin Drive #12-06, Singapore, Singapore, 576151 |
| Phone | 65 6268 6821 |
| Web | https://euda.com |
Wei Chen Latest Insider Activity
Tracking and analyzing the buying and selling activities of Wei Chen against EUDA Health stock is an integral part of due diligence when investing in EUDA Health. Wei Chen insider activity provides valuable insight into whether EUDA Health is net buyers or sellers over its current business cycle. Note, EUDA Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell EUDA Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Wei Chen over a year ago Acquisition or disposition of EUDA Health securities by Wei Chen | ||
Wei Chen over a year ago EUDA Health exotic insider transaction detected |
EUDA Health Management Efficiency
The company has return on total asset (ROA) of (0.863) % which means that it has lost $0.863 on every $100 spent on assets. This is way below average. EUDA Health's management efficiency ratios could be used to measure how well EUDA Health manages its routine affairs as well as how well it operates its assets and liabilities. At present, EUDA Health's Return On Capital Employed is projected to increase slightly based on the last few years of reporting. The current year's Return On Equity is expected to grow to 1.91, whereas Return On Tangible Assets are projected to grow to (7.28). At present, EUDA Health's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 978 K, whereas Total Assets are forecasted to decline to about 1.2 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Richard Brounstein | Heartbeam | 74 | |
| Tyler Danielson | FOXO Technologies | N/A | |
| Ryan Bond | Aclarion | 52 | |
| Lawrence FACS | Nutex Health | 75 | |
| BSN JD | Nutex Health | N/A | |
| Branislav Vajdic | Heartbeam | 69 | |
| LaChoenda Rosales | Nutex Health | N/A | |
| Steven Sabes | FOXO Technologies | 56 | |
| Robert Potashnick | FOXO Technologies | N/A | |
| Lakshmanan Kannappan | Healthcare Triangle | 57 | |
| Jon Bates | Nutex Health | 54 | |
| MD MBA | Nutex Health | 51 | |
| Shibu Kizhakevilayil | Healthcare Triangle | 52 | |
| Vivian MBA | Nutex Health | N/A | |
| Kristi Lane | Healthcare Triangle | N/A | |
| Susan Neo | FOXO Technologies | N/A | |
| Thyagarajan Ramachandran | Healthcare Triangle | 48 | |
| Michael Gill | Healthcare Triangle | 46 | |
| Jim Grauel | FOXO Technologies | N/A | |
| Brian Chen | FOXO Technologies | N/A | |
| John Lorbiecki | Aclarion | 61 | |
Management Performance
| Return On Asset | -0.86 |
EUDA Health Holdings Leadership Team
Elected by the shareholders, the EUDA Health's board of directors comprises two types of representatives: EUDA Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EUDA. The board's role is to monitor EUDA Health's management team and ensure that shareholders' interests are well served. EUDA Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EUDA Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Wei Chen, CEO Director | ||
| Steven Sobak, Chief Officer | ||
| Daniel Tan, Chief Officer | ||
| Alfred Lim, Executive Director | ||
| Jenifer Goh, President Operations | ||
| Whye Tay, Interim CFO | ||
| Yew CPA, Chief Officer |
EUDA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EUDA Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.86 | ||||
| Operating Margin | (0.83) % | ||||
| Current Valuation | 175.88 M | ||||
| Shares Outstanding | 37.15 M | ||||
| Shares Owned By Insiders | 49.35 % | ||||
| Shares Owned By Institutions | 2.47 % | ||||
| Number Of Shares Shorted | 5.04 K | ||||
| Price To Sales | 45.52 X | ||||
| Revenue | 3.71 M | ||||
| Gross Profit | 3.35 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether EUDA Health Holdings is a strong investment it is important to analyze EUDA Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact EUDA Health's future performance. For an informed investment choice regarding EUDA Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EUDA Health Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EUDA Health. If investors know EUDA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EUDA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Revenue Per Share 0.144 | Quarterly Revenue Growth (0.14) | Return On Assets (0.86) |
The market value of EUDA Health Holdings is measured differently than its book value, which is the value of EUDA that is recorded on the company's balance sheet. Investors also form their own opinion of EUDA Health's value that differs from its market value or its book value, called intrinsic value, which is EUDA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EUDA Health's market value can be influenced by many factors that don't directly affect EUDA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EUDA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if EUDA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EUDA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.